Search

Recent news

Amprologix to attend London’s Investival Showcase

Amprologix will be attending the Investival Showcase in London on 18th November 2024 Amprologix will be attending the Investival Showcase in…

Launch of new patent series for AI-designed molecules

Amprologix files the first of a new series of patents protecting novel molecular structures for the treatment of bacterial infections.…

UKRI Innovate UK Logo

Amprologix secures £1M Innovate UK Biomedical Catalyst award…

Innovate UK has awarded Amprologix £1M of Biomedical Catalyst funding to continue the Tobraderm project 1st March 2024 Amprologix is…

Amprologix selected to pitch at the World Innovation…

October 2022 CSO Mat Upton joined 19 other start-ups that were selected from 700 applicants for a place at the…

Amprologix pitch at the BIOCOM/BEAM ALLIANCE AMR Conference,…

April 2022 Gordon Barker, Amprologix CEO was selected to present our innovative antibiotic development approach at the Start-ups Session (https://amr-conference.com/start-ups-amr-conference-pitching-session/).…

News categories

News articles

1 March 2024
Amprologix secures £1M Innovate UK Biomedical Catalyst award funding

Innovate UK has awarded Amprologix £1M of Biomedical Catalyst funding to continue the Tobraderm project 1st March 2024 Amprologix is delighted to receive confirmation of its success in securing a £1M Biomedical Catalyst award from Innovate UK for its Tobraderm project. The project will advance the company’s NI01 lead compound through late-preclinical testing for common […]

Read More
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram